Medical Holography Market Worth $4.04 Billion by 2025 | CAGR: 31.0%: Grand View Research, Inc.
SAN FRANCISCO, June 14, 2018 /PRNewswire/ --
The global medical holography market size is expected to reach USD 4.04 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 31.0% during the forecast period. The market is predominantly driven by increasing adoption of this technique in biomedical research and academic centers. Rising awareness regarding benefits of the technique is one of the key growth stimulators of the market.
Benefits associated with holographic techniques are precise coordination in interventional and diagnostic applications, generation of live images, minimal invasion, and enhanced training. Soaring demand for incorporation of minimally invasive techniques is also projected to boost the growth of the global market. As compared to invasive procedures, these procedures result in lesser trauma and quicker recovery. Another advantage of this procedure is that there is less amount of blood loss as compared to invasive surgery.
Medical holography is anticipated to revolutionize education and training for medical students over the coming years. Traditional teaching methods and textbooks increase the cognitive load on students, which can be reduced by conversion of 2 or 2.5 D representation into a 3D image. According to a study, it has been observed that medical holograms improve the understanding of anatomy compared to traditional methods. Moreover, holographic projections are increasingly being used in various other fields such as aviation, manufacturing, gas, and oil which is estimated to augur well for the holography market.
With increasing burden of chronic diseases and clinical urgency to incorporate technologically advanced products for early and non-invasive diagnosis, medical holography is likely to gain prominence in a wide array of applications. Introduction of new and sophisticated products is poised to shape the future of the market.
Browse full research report with TOC on "Medical Holography Market Analysis Report By Product (Holographic Display, Microscope, Print, Software), By Application (Biomedical Research, Medical Education), By End-use, And Segment Forecasts, 2018 - 2025" at:https://www.grandviewresearch.com/industry-analysis/medical-holography-market
Further Key Findings From the Report Suggest:
The holographic displays segment accounted for 65.8% of the overall revenue in 2016
Semi-transparent displays held 38.8% of the holographic display segment as they can be used to create 3D graphics with enhanced depths and sufficient resolution to provide realistic experience
The microscope segment is expected to witness a remarkable CAGR of 32.3% during the forecast period due to technological advancements in the field of microscopy
The medical education segment is poised to post a CAGR of 31.6% during the forecast period
Research laboratories was the dominant end-use segment, commanding a share of 32.97% in 2016. The substantial share can be attributed to increasing adoption of holography products in research, which primarily involves phase contrast imaging and dynamic live cell imaging
North America led the market with over 37.0% share in 2016 owing to extensive research activities undertaken by a majority of prominent market players
Asia Pacific is anticipated to exhibit a CAGR of over 32.5% during the forecast period.
Browse related reports by Grand View Research:
High Content Screening Market - High Content Screening Market is expected to witness lucrative market growth as a consequence of rising need for development of new drug molecules owing to presence of obsolete drug therapies
Electronic Health Records Market - The global Electronic Health Records (EHR) market size was estimated at USD 20.55 billion in 2016.
eCOA Solutions Market - The global Electronic Clinical Outcome Assessment (eCOA) solutions market size was estimated at USD 616.9 million in 2016.
Telemedicine Market- Telemedicine Market size was valued at USD 24.9 billion in 2016 and is expected to grow at a CAGR of 18.3% over the forecast period.
Grand View Research has segmented the global medical holography market on the basis of product, application, end use, and region:
Medical Holography Product Outlook (Revenue, USD Million, 2014 - 2025)
Holographic Display
Laser
Touchable
Piston
Semi-Transparent
Microscope
Print
Software
Others
Medical Holography Application Outlook (Revenue, USD Million, 2014 - 2025)
Medical Imaging
Ophthalmology
Dentistry
Urology
Otology
Orthopedics
Others
Medical Education
Biomedical Research
Medical Holography End Use Outlook (Revenue, USD Million, 2014 - 2025)
Academic Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Research Laboratories
Medical Holography Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
MEA
South Africa
Explore the BI enabled intuitive market research database,The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ? Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...